Reliance Life Sciences Private Limited recalls Azacitidine for Injection 100mg/Vial
- Recalling company
- Reliance Life Sciences Private Limited
- Product
- Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01
- Reason
- Lack of Sterility Assurance
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jun 24, 2026
- Reported
- Jul 15, 2026
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 8,001 vials
- Lot / codes
- Lot, expiry: RAZM0425A Jun 30, 2027; RAZM0525A Jun 30, 2027; RAZM0725A Jun 30, 2027; RAZM0825A Jun 30, 2027; RAZM0925A Jul 31, 2027; RAZM1125A Jul 31, 2027; RAZM1225A Jul 31, 2027; RAZM1425A Jul 31, 2027; RAZM1525A Jul 31, 2027; RAZM1625A Aug 31, 2027; RAZM1725A Aug 31, 2027; RAZM2025A Sep 30, 2027
- Company location
- Navi Mumbai, N/A
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0674-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0674-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.